193 related articles for article (PubMed ID: 33972152)
1. Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases.
Decker P; Moulinet T; Lopez B; Dubucquoi S; Bonnotte B; Lakomy D; Revuz S; Luc A; Bittencourt MC; Hachulla E; Jaussaud R
Eur J Intern Med; 2021 Sep; 91():45-52. PubMed ID: 33972152
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic features associated with anti-Ro52 autoantibodies in connective tissue diseases patients with interstitial lung disease.
Shi X; Pu X; Cao D; Yan T; Ye Q
Clin Exp Rheumatol; 2023 Nov; 41(11):2257-2263. PubMed ID: 37279146
[TBL] [Abstract][Full Text] [Related]
3. Anti-ro52 antibodies and interstitial lung disease in connective tissue diseases excluding scleroderma.
Ferreira JP; Almeida I; Marinho A; Cerveira C; Vasconcelos C
ISRN Rheumatol; 2012; 2012():415272. PubMed ID: 22567412
[TBL] [Abstract][Full Text] [Related]
4. Anti-Ro52 antibodies in clinical practice: A single-centre experience.
Wu S; Tang X; Wu L; Lu L; Feng X
Int J Clin Pract; 2021 Mar; 75(3):e13679. PubMed ID: 32798318
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies reactive to PEP08 are clinically related with morbidity and severity of interstitial lung disease in connective tissue diseases.
Okumura M; Ozawa T; Hamana H; Norimatsu Y; Tsuda R; Kobayashi E; Shinoda K; Taki H; Tobe K; Imura J; Sugiyama E; Kishi H; Muraguchi A
Eur J Immunol; 2018 Oct; 48(10):1717-1727. PubMed ID: 29989658
[TBL] [Abstract][Full Text] [Related]
6. Presentations and outcomes of interstitial lung disease and the anti-Ro52 autoantibody.
Sclafani A; D'Silva KM; Little BP; Miloslavsky EM; Locascio JJ; Sharma A; Montesi SB
Respir Res; 2019 Nov; 20(1):256. PubMed ID: 31718649
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
Front Immunol; 2019; 10():444. PubMed ID: 30915082
[TBL] [Abstract][Full Text] [Related]
8. Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes.
Mazeda C; Oliveira N; Abreu C; Fraga V; Maduro I; Saraiva A; Inês L; Ferreira C; Correia AM; Nicolau R; Farinha F; Villanueva I; Jesus D; Abreu P; Neto A; Silva Dinis J; Barcelos A
Clin Exp Rheumatol; 2024 Mar; ():. PubMed ID: 38530658
[TBL] [Abstract][Full Text] [Related]
9. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management.
Decker P; Moulinet T; Pontille F; Cravat M; De Carvalho Bittencourt M; Jaussaud R
Autoimmun Rev; 2022 Mar; 21(3):103013. PubMed ID: 34896652
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of myositis antibodies in patients with connective tissue disease-associated interstitial lung diseases].
Xie MM; Zou RY; Li Y; Liu Y; Chen LL; Liu XQ; Zhao Q; Ding JJ; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Oct; 42(10):765-770. PubMed ID: 31594111
[No Abstract] [Full Text] [Related]
11. Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study.
Ghillani P; André C; Toly C; Rouquette AM; Bengoufa D; Nicaise P; Goulvestre C; Gleizes A; Dragon-Durey MA; Alyanakian MA; Chretien P; Chollet-Martin S; Musset L; Weill B; Johanet C
Autoimmun Rev; 2011 Jul; 10(9):509-13. PubMed ID: 21447407
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
[TBL] [Abstract][Full Text] [Related]
13. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V;
Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019
[TBL] [Abstract][Full Text] [Related]
14. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
[TBL] [Abstract][Full Text] [Related]
15. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
Murng SHK; Thomas M
J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
[TBL] [Abstract][Full Text] [Related]
16. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
17. Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.
Wodkowski M; Hudson M; Proudman S; Walker J; Stevens W; Nikpour M; Assassi S; Mayes MD; Wang M; Baron M; Fritzler MJ; ; ;
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S131-5. PubMed ID: 26315678
[TBL] [Abstract][Full Text] [Related]
18. Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis.
Nayebirad S; Mohamadi A; Yousefi-Koma H; Javadi M; Farahmand K; Atef-Yekta R; Tamartash Z; Jameie M; Mohammadzadegan AM; Kavosi H
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 38030264
[TBL] [Abstract][Full Text] [Related]
19. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
[TBL] [Abstract][Full Text] [Related]
20. Serological risk factors for concomitant interstitial lung disease in patients with idiopathic inflammatory myopathy.
Huang HL; Lin WC; Yeh CC; Sun YT
J Clin Neurosci; 2020 Apr; 74():32-35. PubMed ID: 31982271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
